+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Extracorporeal Membrane Oxygenation Machines Market 2024-2028

  • PDF Icon

    Report

  • 168 Pages
  • March 2024
  • Region: Global
  • TechNavio
  • ID: 5509352
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The extracorporeal membrane oxygenation machines market is forecasted to grow by USD 145.04 million during 2023-2028, accelerating at a CAGR of 5.92% during the forecast period. The report on the extracorporeal membrane oxygenation machines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of respiratory and heart failure, rising number of new product launches, and growing number of organ transplant procedures.

The extracorporeal membrane oxygenation machines market is segmented as below:

By Modality

  • Veno-venous and arterio-venous
  • Veno-arterial

By Product

  • ECMO machines
  • Softwares

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the technological advancements in ECMO machines as one of the prime reasons driving the extracorporeal membrane oxygenation machines market growth during the next few years. Also, favorable outcomes in patients with respiratory failure due to use of ECMO machines and increasing adoption of ECMO machines in pediatric care and treatment will lead to sizable demand in the market.

The report on the extracorporeal membrane oxygenation machines market covers the following areas:

  • Extracorporeal membrane oxygenation machines market sizing
  • Extracorporeal membrane oxygenation machines market forecast
  • Extracorporeal membrane oxygenation machines market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading extracorporeal membrane oxygenation machines market vendors that include Abbott Laboratories, Braile Biomedica, Chalice Medical Ltd., CytoSorbents Corp., Edwards Lifesciences Corp., Eurosets Srl, Fresenius SE and Co. KGaA, Gen World Medical Devices, Getinge AB, Johnson and Johnson Services Inc., LivaNova PLC, MC3 Cardiopulmonary, Medtronic, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Sechrist Industries Inc., Senko Medical Instrument Mfg. Co. Ltd., Spectrum Medical Ltd., and Terumo Corp.. Also, the extracorporeal membrane oxygenation machines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Modality
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global extracorporeal membrane oxygenation machines market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global extracorporeal membrane oxygenation machines market 2018 - 2022 ($ million)
4.2 Modality Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Modality Segment 2018 - 2022 ($ million)
4.3 Modality Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Modality Segment 2018 - 2022 ($ million)
4.4 Product Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.5 Geography Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.6 Country Segment Analysis 2018 - 2022
Exhibit 23: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 24: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 25: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 26: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 27: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 28: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 29: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 30: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Modality
6.1 Market segments
Exhibit 31: Chart on Modality - Market share 2023-2028 (%)
Exhibit 32: Data Table on Modality - Market share 2023-2028 (%)
6.2 Comparison by Modality
Exhibit 33: Chart on Comparison by Modality
Exhibit 34: Data Table on Comparison by Modality
6.3 Veno-venous and arterio-venous - Market size and forecast 2023-2028
Exhibit 35: Chart on Veno-venous and arterio-venous - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Data Table on Veno-venous and arterio-venous - Market size and forecast 2023-2028 ($ million)
Exhibit 37: Chart on Veno-venous and arterio-venous - Year-over-year growth 2023-2028 (%)
Exhibit 38: Data Table on Veno-venous and arterio-venous - Year-over-year growth 2023-2028 (%)
6.4 Veno-arterial - Market size and forecast 2023-2028
Exhibit 39: Chart on Veno-arterial - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Data Table on Veno-arterial - Market size and forecast 2023-2028 ($ million)
Exhibit 41: Chart on Veno-arterial - Year-over-year growth 2023-2028 (%)
Exhibit 42: Data Table on Veno-arterial - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Modality
Exhibit 43: Market opportunity by Modality ($ million)
Exhibit 44: Data Table on Market opportunity by Modality ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 45: Chart on Product - Market share 2023-2028 (%)
Exhibit 46: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 47: Chart on Comparison by Product
Exhibit 48: Data Table on Comparison by Product
7.3 ECMO machines - Market size and forecast 2023-2028
Exhibit 49: Chart on ECMO machines - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Data Table on ECMO machines - Market size and forecast 2023-2028 ($ million)
Exhibit 51: Chart on ECMO machines - Year-over-year growth 2023-2028 (%)
Exhibit 52: Data Table on ECMO machines - Year-over-year growth 2023-2028 (%)
7.4 Softwares - Market size and forecast 2023-2028
Exhibit 53: Chart on Softwares - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Data Table on Softwares - Market size and forecast 2023-2028 ($ million)
Exhibit 55: Chart on Softwares - Year-over-year growth 2023-2028 (%)
Exhibit 56: Data Table on Softwares - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Exhibit 57: Market opportunity by Product ($ million)
Exhibit 58: Data Table on Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 60: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 61: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 62: Chart on Geographic comparison
Exhibit 63: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 64: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 66: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 68: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 70: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 72: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 74: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 75: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 76: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 78: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 79: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 80: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 82: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 83: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 84: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 86: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 87: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 88: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 90: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 91: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 92: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 94: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 95: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 96: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 98: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 99: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 100: Market opportunity By Geographical Landscape ($ million)
Exhibit 101: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 108: Abbott Laboratories - Overview
Exhibit 109: Abbott Laboratories - Business segments
Exhibit 110: Abbott Laboratories - Key offerings
Exhibit 111: Abbott Laboratories - Segment focus
12.4 Braile Biomedica
Exhibit 112: Braile Biomedica - Overview
Exhibit 113: Braile Biomedica - Product / Service
Exhibit 114: Braile Biomedica - Key offerings
12.5 Chalice Medical Ltd.
Exhibit 115: Chalice Medical Ltd. - Overview
Exhibit 116: Chalice Medical Ltd. - Product / Service
Exhibit 117: Chalice Medical Ltd. - Key offerings
12.6 Eurosets Srl
Exhibit 118: Eurosets Srl - Overview
Exhibit 119: Eurosets Srl - Product / Service
Exhibit 120: Eurosets Srl - Key offerings
12.7 Fresenius SE and Co. KGaA
Exhibit 121: Fresenius SE and Co. KGaA - Overview
Exhibit 122: Fresenius SE and Co. KGaA - Business segments
Exhibit 123: Fresenius SE and Co. KGaA - Key news
Exhibit 124: Fresenius SE and Co. KGaA - Key offerings
Exhibit 125: Fresenius SE and Co. KGaA - Segment focus
12.8 Getinge AB
Exhibit 126: Getinge AB - Overview
Exhibit 127: Getinge AB - Business segments
Exhibit 128: Getinge AB - Key news
Exhibit 129: Getinge AB - Key offerings
Exhibit 130: Getinge AB - Segment focus
12.9 LivaNova PLC
Exhibit 131: LivaNova PLC - Overview
Exhibit 132: LivaNova PLC - Business segments
Exhibit 133: LivaNova PLC - Key news
Exhibit 134: LivaNova PLC - Key offerings
Exhibit 135: LivaNova PLC - Segment focus
12.10 MC3 Cardiopulmonary
Exhibit 136: MC3 Cardiopulmonary - Overview
Exhibit 137: MC3 Cardiopulmonary - Product / Service
Exhibit 138: MC3 Cardiopulmonary - Key offerings
12.11 Medtronic
Exhibit 139: Medtronic - Overview
Exhibit 140: Medtronic - Business segments
Exhibit 141: Medtronic - Key news
Exhibit 142: Medtronic - Key offerings
Exhibit 143: Medtronic - Segment focus
12.12 MicroPort Scientific Corp.
Exhibit 144: MicroPort Scientific Corp. - Overview
Exhibit 145: MicroPort Scientific Corp. - Business segments
Exhibit 146: MicroPort Scientific Corp. - Key offerings
Exhibit 147: MicroPort Scientific Corp. - Segment focus
12.13 Nipro Corp.
Exhibit 148: Nipro Corp. - Overview
Exhibit 149: Nipro Corp. - Business segments
Exhibit 150: Nipro Corp. - Key offerings
Exhibit 151: Nipro Corp. - Segment focus
12.14 OriGen Biomedical Inc.
Exhibit 152: OriGen Biomedical Inc. - Overview
Exhibit 153: OriGen Biomedical Inc. - Product / Service
Exhibit 154: OriGen Biomedical Inc. - Key offerings
12.15 Sechrist Industries Inc.
Exhibit 155: Sechrist Industries Inc. - Overview
Exhibit 156: Sechrist Industries Inc. - Product / Service
Exhibit 157: Sechrist Industries Inc. - Key offerings
12.16 Senko Medical Instrument Mfg. Co. Ltd.
Exhibit 158: Senko Medical Instrument Mfg. Co. Ltd. - Overview
Exhibit 159: Senko Medical Instrument Mfg. Co. Ltd. - Product / Service
Exhibit 160: Senko Medical Instrument Mfg. Co. Ltd. - Key offerings
12.17 Terumo Corp.
Exhibit 161: Terumo Corp. - Overview
Exhibit 162: Terumo Corp. - Business segments
Exhibit 163: Terumo Corp. - Key news
Exhibit 164: Terumo Corp. - Key offerings
Exhibit 165: Terumo Corp. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 166: Inclusions checklist
Exhibit 167: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 168: Currency conversion rates for US$
13.4 Research methodology
Exhibit 169: Research methodology
Exhibit 170: Validation techniques employed for market sizing
Exhibit 171: Information sources
13.5 List of abbreviations
Exhibit 172: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Modality
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global extracorporeal membrane oxygenation machines market 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - Modality Segment 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Modality Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 24: Five forces analysis - Comparison between 2023 and 2028
Exhibits 25: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 26: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 30: Chart on Market condition - Five forces 2023 and 2028
Exhibits 31: Chart on Modality - Market share 2023-2028 (%)
Exhibits 32: Data Table on Modality - Market share 2023-2028 (%)
Exhibits 33: Chart on Comparison by Modality
Exhibits 34: Data Table on Comparison by Modality
Exhibits 35: Chart on Veno-venous and arterio-venous - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Data Table on Veno-venous and arterio-venous - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Chart on Veno-venous and arterio-venous - Year-over-year growth 2023-2028 (%)
Exhibits 38: Data Table on Veno-venous and arterio-venous - Year-over-year growth 2023-2028 (%)
Exhibits 39: Chart on Veno-arterial - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Data Table on Veno-arterial - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Chart on Veno-arterial - Year-over-year growth 2023-2028 (%)
Exhibits 42: Data Table on Veno-arterial - Year-over-year growth 2023-2028 (%)
Exhibits 43: Market opportunity by Modality ($ million)
Exhibits 44: Data Table on Market opportunity by Modality ($ million)
Exhibits 45: Chart on Product - Market share 2023-2028 (%)
Exhibits 46: Data Table on Product - Market share 2023-2028 (%)
Exhibits 47: Chart on Comparison by Product
Exhibits 48: Data Table on Comparison by Product
Exhibits 49: Chart on ECMO machines - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on ECMO machines - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on ECMO machines - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on ECMO machines - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Softwares - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Softwares - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Softwares - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Softwares - Year-over-year growth 2023-2028 (%)
Exhibits 57: Market opportunity by Product ($ million)
Exhibits 58: Data Table on Market opportunity by Product ($ million)
Exhibits 59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 60: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 61: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 62: Chart on Geographic comparison
Exhibits 63: Data Table on Geographic comparison
Exhibits 64: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 67: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 68: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 71: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 72: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 73: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 75: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 76: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 77: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 79: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 80: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 81: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 83: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 84: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 85: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 87: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 88: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 89: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 91: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 92: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 93: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 95: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 96: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 97: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 99: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 100: Market opportunity By Geographical Landscape ($ million)
Exhibits 101: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 102: Impact of drivers and challenges in 2023 and 2028
Exhibits 103: Overview on Criticality of inputs and Factors of differentiation
Exhibits 104: Overview on factors of disruption
Exhibits 105: Impact of key risks on business
Exhibits 106: Vendors covered
Exhibits 107: Matrix on vendor position and classification
Exhibits 108: Abbott Laboratories - Overview
Exhibits 109: Abbott Laboratories - Business segments
Exhibits 110: Abbott Laboratories - Key offerings
Exhibits 111: Abbott Laboratories - Segment focus
Exhibits 112: Braile Biomedica - Overview
Exhibits 113: Braile Biomedica - Product / Service
Exhibits 114: Braile Biomedica - Key offerings
Exhibits 115: Chalice Medical Ltd. - Overview
Exhibits 116: Chalice Medical Ltd. - Product / Service
Exhibits 117: Chalice Medical Ltd. - Key offerings
Exhibits 118: Eurosets Srl - Overview
Exhibits 119: Eurosets Srl - Product / Service
Exhibits 120: Eurosets Srl - Key offerings
Exhibits 121: Fresenius SE and Co. KGaA - Overview
Exhibits 122: Fresenius SE and Co. KGaA - Business segments
Exhibits 123: Fresenius SE and Co. KGaA - Key news
Exhibits 124: Fresenius SE and Co. KGaA - Key offerings
Exhibits 125: Fresenius SE and Co. KGaA - Segment focus
Exhibits 126: Getinge AB - Overview
Exhibits 127: Getinge AB - Business segments
Exhibits 128: Getinge AB - Key news
Exhibits 129: Getinge AB - Key offerings
Exhibits 130: Getinge AB - Segment focus
Exhibits 131: LivaNova PLC - Overview
Exhibits 132: LivaNova PLC - Business segments
Exhibits 133: LivaNova PLC - Key news
Exhibits 134: LivaNova PLC - Key offerings
Exhibits 135: LivaNova PLC - Segment focus
Exhibits 136: MC3 Cardiopulmonary - Overview
Exhibits 137: MC3 Cardiopulmonary - Product / Service
Exhibits 138: MC3 Cardiopulmonary - Key offerings
Exhibits 139: Medtronic - Overview
Exhibits 140: Medtronic - Business segments
Exhibits 141: Medtronic - Key news
Exhibits 142: Medtronic - Key offerings
Exhibits 143: Medtronic - Segment focus
Exhibits 144: MicroPort Scientific Corp. - Overview
Exhibits 145: MicroPort Scientific Corp. - Business segments
Exhibits 146: MicroPort Scientific Corp. - Key offerings
Exhibits 147: MicroPort Scientific Corp. - Segment focus
Exhibits 148: Nipro Corp. - Overview
Exhibits 149: Nipro Corp. - Business segments
Exhibits 150: Nipro Corp. - Key offerings
Exhibits 151: Nipro Corp. - Segment focus
Exhibits 152: OriGen Biomedical Inc. - Overview
Exhibits 153: OriGen Biomedical Inc. - Product / Service
Exhibits 154: OriGen Biomedical Inc. - Key offerings
Exhibits 155: Sechrist Industries Inc. - Overview
Exhibits 156: Sechrist Industries Inc. - Product / Service
Exhibits 157: Sechrist Industries Inc. - Key offerings
Exhibits 158: Senko Medical Instrument Mfg. Co. Ltd. - Overview
Exhibits 159: Senko Medical Instrument Mfg. Co. Ltd. - Product / Service
Exhibits 160: Senko Medical Instrument Mfg. Co. Ltd. - Key offerings
Exhibits 161: Terumo Corp. - Overview
Exhibits 162: Terumo Corp. - Business segments
Exhibits 163: Terumo Corp. - Key news
Exhibits 164: Terumo Corp. - Key offerings
Exhibits 165: Terumo Corp. - Segment focus
Exhibits 166: Inclusions checklist
Exhibits 167: Exclusions checklist
Exhibits 168: Currency conversion rates for US$
Exhibits 169: Research methodology
Exhibits 170: Validation techniques employed for market sizing
Exhibits 171: Information sources
Exhibits 172: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global extracorporeal membrane oxygenation machines market: Abbott Laboratories, Braile Biomedica, Chalice Medical Ltd., CytoSorbents Corp., Edwards Lifesciences Corp., Eurosets Srl, Fresenius SE and Co. KGaA, Gen World Medical Devices, Getinge AB, Johnson and Johnson Services Inc., LivaNova PLC, MC3 Cardiopulmonary, Medtronic, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Sechrist Industries Inc., Senko Medical Instrument Mfg. Co. Ltd., Spectrum Medical Ltd., and Terumo Corp..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advancements in ECMO machines."

According to the report, one of the major drivers for this market is the increasing incidence of respiratory and heart failure.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Braile Biomedica
  • Chalice Medical Ltd.
  • CytoSorbents Corp.
  • Edwards Lifesciences Corp.
  • Eurosets Srl
  • Fresenius SE and Co. KGaA
  • Gen World Medical Devices
  • Getinge AB
  • Johnson and Johnson Services Inc.
  • LivaNova PLC
  • MC3 Cardiopulmonary
  • Medtronic
  • MicroPort Scientific Corp.
  • Nipro Corp.
  • OriGen Biomedical Inc.
  • Sechrist Industries Inc.
  • Senko Medical Instrument Mfg. Co. Ltd.
  • Spectrum Medical Ltd.
  • Terumo Corp.